USANA Health Sciences (NYSE:USNA) Releases Earnings Results, Misses Expectations By $0.22 EPS

USANA Health Sciences (NYSE:USNA) posted its earnings results on Tuesday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.22), FiscalAI reports. The company had revenue of $205.89 million for the quarter, compared to analyst estimates of $217.42 million. USANA Health Sciences had a positive return on equity of 3.41% and a negative net margin of 2.43%.

USANA Health Sciences Stock Up 1.3%

Shares of USANA Health Sciences stock opened at $14.91 on Wednesday. The stock has a market capitalization of $275.46 million, a price-to-earnings ratio of -12.32, a price-to-earnings-growth ratio of 1.61 and a beta of 0.66. USANA Health Sciences has a twelve month low of $12.57 and a twelve month high of $23.59. The company has a 50-day simple moving average of $14.60 and a two-hundred day simple moving average of $18.07.

Analysts Set New Price Targets

Several research analysts have weighed in on USNA shares. Wall Street Zen cut shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings restated a “sell (d)” rating on shares of USANA Health Sciences in a report on Monday, September 21st. Finally, Zacks Research upgraded USANA Health Sciences from a “strong sell” rating to a “hold” rating in a report on Monday, October 5th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

About USANA Health Sciences

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.